PPT-Handling Iatrogenic Disasters in Prescription Drug Abuse

Allen County Providers Respond Prescription Drug Symposium October 2015 The Crisis Deborah A McMahan MD Agenda Issue Solutions Why Worry Provider Perspective Issue httpwwwdmueduwpcontentuploads201411americanopioidusage375x468png. The Child Ab use Prevention and Treatment Act CAPTA has these definitions Child abuse and neglect At a minimum any recent act or failure to act o n the part of a parent or caretaker which results in death serious physical or emotional harm sexual a Coalitions . should feel free to adapt . the following . slides into their education and outreach activities. Here’s what you’ll . find:. About this presentation. The Teen – Rx Abuse Connection. Hyaloid. Face during 23-Gauge Pars Plana . Vitrectomy. Murray CD, . Rahman. R, Stephenson J. Purpose . Describe incidence and features of intraoperative retinal breaks caused by iatrogenic separation of the posterior . Charlene M. Dewey, M.D., M.Ed., FACP. Associate Professor of Medical Education and Administration. Associate Professor of Medicine. Co-Director, Center for Professional Health. Vanderbilt University Medical Center. 2007 - 2011 . Prepared By: . Shreenath Shah and Michael Spence . Pharm D. Candidates 2013. Ferris State University College of Pharmacy . This . power point presentation was . developed in part under grant number 15722 from the Office of National Drug Control Policy and Substance Abuse and Mental Health Services Administration, U.S. Department of Health and  Human Services.  The views policies, and opinions expressed here are those of the authors and do not necessarily reflect those of ONDCP, SAMHSA, or HHS. A Community Perspective. Prescription Drugs and Abuse in Women: A Community Perspective. One person dies every 19 minutes from prescription drug abuse in the United States (CDC). According to the Centers for Disease Control and Prevention (CDC) an estimate of twenty –seven thousand unintentional drug overdose deaths occurred in 2007. The views and opinions expressed in this presentation are those of the author and do not reflect official policy or position of the United States Air Force, Department of Defense, or US Government. Case 1. in . the Workplace. Tess Benham, Sr. Program Manager, National Safety Council. Dr. Denise Fields, . PharmD. , Sr. Clinical Consultant, Express Scripts. Tamara Watson, Master Trooper, Indiana State Police. Improving . Clinical Decision-Making and Supporting a Pharmacist’s Professional Judgment. Connor W Norwood, MHA. Assistant Director, Health Workforce Studies Program. Visiting Research Associate, Department of Family . October 28, 2015. An “epidemic of consequences” -. Drug overdose death rates continue to increase. NCHS Data Brief, December, 2011, . Updated with 2009 and 2010 mortality data. 2. Who is overdosing?. Bob Twillman, Ph.D., FAPM. Executive . Director. American . Academy of Pain Management. Two Major Public Health Problems. Prescription . opioid abuse. :. 12.5 million non-medical users per year. $70-120 billion cost per year. Learning Objectives. Participants will be able to:. Associate the history of prescription drug use in America with the current trend of prescription drug abuse;. Differentiate between the three most commonly abused types of prescription drugs; and. Gil Kerlikowske, . Director. White House Office of National Drug Control Policy. 2. ONDCP’s Authority. Established by the Anti-Drug Abuse Act of 1988. Principal purpose: Establish policies, priorities, and objectives for the nation's drug control program. CONTENTS Table of ContentsAcknowledgementsIntroductionIllegal Prescription Drug ThreatWhat are Controlled Prescription Drugs?What is Diversion?Unscrupulous Physicians and PharmacistsDoctor ShoppingSha